Clinical Trial Update: Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin type A to prevent complications after esophageal cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Carcinoma

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-02-16